PRELIMINARY CHROMATOGRAPHIC INVESTIGATION OF FOUR STACHYS SPP. (LAMIACEAE) FROM OLTENIA FLORA

Concerning four Stachys spp. (Lamiaceae) from the Oltenia flora, the paper highlights the polyphenolic content of aerial parts through high-performance thin-layer chromatography coupled with photodensitometry. Chlorogenic acid (CA) was identified and quantified in all 20% methanolic extracts of Stachydisherba. The highest CA amount was determined in S. recta (59.88 mg%), followed by S. sylvatica (32.90 mg%), S. officinalis (31.34 mg%), and S. germanica (25.16 mg%), respectively

PRELIMINARY CHROMATOGRAPHICRESEARCH ON SOME SALVIA SPP. (LAMIACEAE)

Salvia genus, representative for the Lamiaceae family as it comprises approximately one thousand different species, is considered for a wide plethora of therapeutic actions, such as antioxidant, anti-inflammatory, hepatoprotective, antitumoral and antidiabetic activity. The paper presents the preliminary chromatographic investigations of the polyphenols in the aerial parts of some Salvia spp. Using high-performance thin-layer chromatography (HPTLC) coupled with photodensitometry, caffeic acid was identified and quantified in the 20% methanolic extracts of Salviaeherba, in descending order, as follows: S. nemorosa (3.096%) > S. verticillata (3.041%) > S. sclarea (2.663%) > S. glutinosa (1.962%) > S. aethiopis (0.926%)

HISTO-ANATOMICAL AND CHROMATOGRAPHIC RESEARCHES ON CAMPANULA PERSICIFOLIA L. (CAMPANULACEAE) SPECIES

The paper presents the histo-anatomical researches on root, rhizome, aboveground stem and leaf of Campanula persicifolia L. (Campanulaceae) species, together with the thin-layer chromatography analysis of the polyphenols content of Campanulae persicifoliae herba. Chlorogenic acid (108.6 μg/mL) was identified in the 20% methanolic extract of the aerial parts

Microbiota-Accessible Boron-Containing Compounds in Complex Regional Pain Syndrome

The microbiota–gut–brain axis has garnered increasing attention in recent years for its role in various health conditions, including neuroinflammatory disorders like complex regional pain syndrome (CRPS). CRPS is a debilitating condition characterized by chronic neuropathic pain, and its etiology and pathophysiology remain elusive. Emerging research suggests that alterations in the gut microbiota composition and function could play a significant role in CRPS development and progression. Our paper explores the implications of microbiota in CRPS and the potential therapeutic role of boron (B). Studies have demonstrated that individuals with CRPS often exhibit dysbiosis, with imbalances in beneficial and pathogenic gut bacteria. Dysbiosis can lead to increased gut permeability and systemic inflammation, contributing to the chronic pain experienced in CRPS. B, an essential trace element, has shown promise in modulating the gut microbiome positively and exerting anti-inflammatory effects. Recent preclinical and clinical studies suggest that B supplementation may alleviate neuropathic pain and improve CRPS symptoms by restoring microbiota balance and reducing inflammation. Our review highlights the complex interplay between microbiota, inflammation, and neuropathic pain in CRPS and underscores the potential of B as a novel therapeutic approach to target the microbiota–gut–brain axis, offering hope for improved management of this challenging condition

New Insights into Boron Essentiality in Humans and Animals

Boron (B) is considered a prebiotic chemical element with a role in both the origin and evolution of life, as well as an essential micronutrient for some bacteria, plants, fungi, and algae. B has beneficial effects on the biological functions of humans and animals, such as reproduction, growth, calcium metabolism, bone formation, energy metabolism, immunity, and brain function. Naturally organic B (NOB) species may become promising novel prebiotic candidates. NOB-containing compounds have been shown to be essential for the symbiosis between organisms from different kingdoms. New insights into the key role of NOB species in the symbiosis between human/animal hosts and their microbiota will influence the use of natural B-based colon-targeting nutraceuticals. The mechanism of action (MoA) of NOB species is related to the B signaling molecule (autoinducer-2-borate (AI-2B)) as well as the fortification of the colonic mucus gel layer with NOB species from B-rich prebiotic diets. Both the microbiota and the colonic mucus gel layer can become NOB targets. This paper reviews the evidence supporting the essentiality of the NOB species in the symbiosis between the microbiota and the human/animal hosts, with the stated aim of highlighting the MoA and targets of these species